drug protocol number

AG348-C-018

drug sponsor

Agios Pharmaceuticals, Inc.

drug study

Mitapivat

drug trial site

King Khalid University Hospital (Riyadh),King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Hospital NG (Al Ahsa)

drug status

Ongoing

drug phase